Watson Pharma Recalls Vancomycin Capsules Due to Subpotency
Actavis/Watson recalls 26,663 cartons of Vancomycin Hydrochloride Capsules (125 mg) due to subpotent drug issues. Check your lot numbers.
Use caution until it’s fixed
Subpotent Drug
Contact the company
What happened, in plain English
Actavis Inc is recalling Vancomycin Hydrochloride Capsule, USP, 125 mg, distributed by Watson Pharma. The recall was issued because the drug may be subpotent, meaning it might not contain the full amount of active ingredient needed to treat infections effectively. Approximately 26,663 cartons were affected and distributed nationwide. Read more at govinfonow.com/recall/45895-actavis-inc-recalls-vancomycin-hydrochloride-capsule-usp-125-mg-20.
Source Summary by GovInfoNow · govinfonow.com/recall/45895-actavis-inc-recalls-vancomycin-hydrochloride-capsule-usp-125-mg-20 · Updated October 12, 2026 · FDA enforcement record: FDA #D-0232-2015
Cite this page
“Watson Pharma Recalls Vancomycin Capsules Due to Subpotency.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45895-actavis-inc-recalls-vancomycin-hydrochloride-capsule-usp-125-mg-20. Based on FDA recall #D-0232-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0232-2015%22&limit=1).
Why it’s dangerous
The primary hazard is that the drug is subpotent. This means the capsules may contain less than the labeled amount of Vancomycin Hydrochloride, potentially leading to treatment failure for serious infections if the patient relies on them without medical supervision.
Who’s affected
Patients who have been prescribed Vancomycin Hydrochloride Capsules, USP, 125 mg by Watson Pharma. Inc. are at risk of receiving medication that may not work as intended to treat bacterial infections.
How to tell if you have this one
Look for Vancomycin Hydrochloride Capsule, USP, 125 mg in a 20-count blister pack. The product is manufactured for Watson Pharma. Inc. and distributed by Actavis Inc. Check the NDC 0591-3560-15 and UPC Code 3-0591356015-4 on the packaging. Affected lots include 3103681 (exp Aug 2014), 3104886 (exp Oct 2014), 3105836 (exp Dec 2014), and 3106650 (exp Dec 2014).
- Brand
Watson Pharma- Product
Vancomycin Hydrochloride Capsule, USP, 125 mg, 20 count blister pack, Rx Only, Mfd. for: Watson Pharma. Inc- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0232-2015 | Vancomycin Hydrochloride Capsule, USP, 125 mg, 20 count blister pack, Rx Only, Mfd. for: Watson Pharma. Inc. Parsippany, NJ 07054 USA, Mfd. by: Patheon Pharmaceuticals Inc. Cincinnati, OH 45237 USA ---- NDC 0591-3560-15 UPC Code 3-0591356015-4; 3103681, exp Aug 2014, 3104886, exp Oct 2014, 3105836, exp Dec 2014, and 3106650, exp Dec 2014 | 26,663 cartons |
| D-0233-2015 | Vancomycin Hydrochloride Capsule, USP, 250 mg, 20 count blister pack, Rx Only, Mfd. for: Watson Pharma. Inc. Parsippany, NJ 07054 USA, Mfd. by: Patheon Pharmaceuticals Inc. Cincinnati, OH 45237 USA ---- NDC 0591-3561-15 UPC 3-3-0591356115-1; 3101178, exp Aug 2014, 3104318, exp Aug 2014, 3104319, exp Oct 2014, 3104889, exp Oct 2014, 3104891, exp Oct 2014, 3104893, exp Oct 2014, and 3106651, exp Dec 2014 | 46,676 cartons |
What to do — step by step
Contact Your Doctor
If you are taking this medication, contact your healthcare provider immediately to discuss alternative treatment options.
Check Lot Numbers
Verify if your specific carton matches the recalled lot numbers (3103681, 3104886, 3105836, or 3106650) and expiration dates (Aug 2014, Oct 2014, or Dec 2014).
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3.6 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0232-2015 (August 25, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0232-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.